Search

Your search keyword '"Julian Malicki"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Julian Malicki" Remove constraint Author: "Julian Malicki"
199 results on '"Julian Malicki"'

Search Results

1. Navigating challenges: optimising methods for primary cell culture isolation

2. Value of [18F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer

3. Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost

6. Differences among [18F]FDG PET-derived parameters in lung cancer produced by three software packages

8. Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres

10. Multicentre clinical radiotherapy audit in rectal cancer: results of the IROCA project

11. Role of Interleukins and New Perspectives in Mechanisms of Resistance to Chemotherapy in Gastric Cancer

12. Nontarget and Out-of-Field Doses from Electron Beam Radiotherapy

13. Criteria for Verification and Replanning Based on the Adaptive Radiotherapy Protocol 'Best for Adaptive Radiotherapy' in Head and Neck Cancer

14. Influence of Specific Treatment Parameters on Nontarget and Out-of-Field Doses in a Phantom Model of Prostate SBRT with CyberKnife and TrueBeam

15. Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer

16. Thermal Boost to Breast Tumor Bed—New Technique Description, Treatment Application and Example Clinical Results

17. Influence of length of interval between pulses in PDR brachytherapy (PDRBT) on value of Biologically Equivalent Dose (BED) in healthy tissues

18. Evaluation and risk factors of volume and dose differences of selected structures in patients with head and neck cancer treated on Helical TomoTherapy by using Deformable Image Registration tool

21. Verification of electron beam parameters in an intraoperative linear accelerator using dosimetric and radiobiological response methods

22. Optimisation of methods for isolation of primary cancer cells from breast cancer tumour

23. Treatment-integrated imaging, radiomics, and personalised radiotherapy: the future is at hand

24. Dosimetric assessment of the impact of low-cost materials used in stereolithography in high-dose-rate brachytherapy

25. Management of Onsite and Remote Communication in Oncology Hospitals: Data Protection in an Era of Rapid Technological Advances

26. The impact of different optimization strategies on the agreement between planned and delivered doses during volumetric modulated arc therapy for total marrow irradiation

27. 3D-printed surface applicators for brachytherapy: a phantom study

28. Deep inspiration breath hold reduces the mean heart dose in left breast cancer radiotherapy

29. Impact of COVID-19 on the performance of a radiation oncology department at a major comprehensive cancer centre in Poland during the first ten weeks of the epidemic

30. Cancer incidence in the Greater Poland region as compared to Europe

31. Impact of different optimization strategies on the compatibility between planned and delivered doses during radiation therapy of cervical cancer

32. Evolution of treatment planning and dose delivery methods during radiotherapy for patients undergoing bone marrow transplantation: a review

33. Cellular Damage in the Target and Out-Of-Field Peripheral Organs during VMAT SBRT Prostate Radiotherapy: An In Vitro Phantom-Based Study

35. Development of a quasi‐humanoid phantom to perform dosimetric and radiobiological measurements for out‐of‐field doses from external beam radiation therapy

36. FLASH radiotherapy: an emerging approach in radiation therapy

37. Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy

38. Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?

40. Comparison of dose distributions for 6MV and 15MV energy for Total Body Irradiation (TBI)

41. Calculation and measurement of doses in the surface layers of a phantom when using Tomotherapy

42. Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres

43. Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy

44. Differences between TNM classification and 2-[18F]FDG PET parameters of primary tumor in NSCLC patients

45. PO-1785 Non-target dose reduction at phantom study for prostate radiotherapy using TrueBeam and CyberKnife

47. Multicentre clinical radiotherapy audit in rectal cancer: results of the IROCA project

48. How public health services pay for radiotherapy in Europe:an ESTRO-HERO analysis of reimbursement

49. Carcinogenesis induced by low-dose radiation

50. Improving radiation oncology through clinical audits: Introducing the IROCA project

Catalog

Books, media, physical & digital resources